| |
Loop diuretic use
|
p value
|
|---|
|
Yes (n = 2364)
|
No (n = 2364)
|
|---|
|
n
|
%
|
n
|
%
|
|---|
|
Age (years)
|
0.645
|
|
< 60
|
398
|
16.8
|
375
|
15.9
| |
|
60–79
|
1306
|
55.3
|
1314
|
55.6
|
|
≥ 80
|
660
|
27.9
|
675
|
28.5
|
|
Gender
|
0.792
|
|
Male
|
1344
|
56.9
|
1335
|
56.5
| |
|
Female
|
1020
|
43.1
|
1029
|
43.5
|
|
Income level (NTD)
|
0.215
|
|
Financially dependent
|
822
|
34.8
|
821
|
34.7
| |
|
1–19,999
|
1283
|
54.3
|
1323
|
56.0
|
|
20,000–39,999
|
188
|
7.9
|
167
|
7.1
|
|
≥ 40,000
|
71
|
3.0
|
53
|
2.2
|
|
Urbanization level
|
0.943
|
|
1 (Most urbanized)
|
542
|
22.9
|
541
|
22.9
| |
|
2
|
604
|
25.6
|
612
|
25.9
|
|
3
|
403
|
17.1
|
402
|
17.0
|
|
4
|
469
|
19.8
|
449
|
19.0
|
|
5 (Least urbanized)
|
346
|
14.6
|
360
|
15.2
|
|
Stroke type
|
0.524
|
|
Ischemic
|
1431
|
60.5
|
1467
|
62.0
| |
|
Hemorrhagic
|
373
|
15.8
|
380
|
16.1
|
|
TIA
|
321
|
13.6
|
298
|
12.6
|
|
Others
|
239
|
10.1
|
219
|
9.3
|
|
Charlson comorbidity index
|
0.415
|
|
1–2
|
1073
|
45.4
|
1110
|
47.0
| |
|
3–4
|
774
|
32.7
|
733
|
31.0
|
|
≥ 5
|
517
|
21.9
|
521
|
22.0
|
|
Hypertension
|
1840
|
77.8
|
1854
|
78.4
|
0.622
|
|
Diabetes mellitus
|
970
|
41.0
|
976
|
41.3
|
0.859
|
|
COPD
|
646
|
27.3
|
657
|
27.8
|
0.720
|
|
Congestive heart failure
|
459
|
19.4
|
427
|
18.1
|
0.233
|
|
Chronic liver disease
|
299
|
12.7
|
288
|
12.2
|
0.628
|
|
Chronic kidney disease
|
379
|
16.0
|
355
|
15.0
|
0.335
|
|
Osteoporosis
|
133
|
5.6
|
133
|
5.6
|
1.000
|
|
Malignancy
|
190
|
8.0
|
170
|
7.2
|
0.273
|
|
Dementia
|
169
|
7.1
|
154
|
6.5
|
0.387
|
|
Depression
|
139
|
5.9
|
128
|
5.4
|
0.488
|
|
Epilepsy
|
46
|
1.9
|
39
|
1.6
|
0.444
|
|
Parkinsonism
|
121
|
5.1
|
122
|
5.2
|
0.947
|
- A χ2 test was used to compare the differences between the two groups
- Abbreviations: NTD New Taiwan dollars, COPD chronic obstructive pulmonary disease, TIA transient ischemic attack
